Biochemical Marker for Menkes Disease
Abstract
Plasma and CSF levels of catechols in 10 patients with Menkes disease, ranging in age from 9 days to 27 months, were compared with control groups and patients with congenital absence of dopamine-B-hydroxylase (DBH) at the National Institutes of Health, Bethesda, MD.
DOI: https://doi.org/10.15844/pedneurbriefs-7-2-7 | Journal eISSN: 2166-6482
Language: English
Page range: 12 - 13
Published on: Feb 1, 1993
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1993 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.